BeStock  
Stocks › Biotechnology › COGT

Cogent Biosciences COGT

US equityMarket cap rank #2102Biotechnology
$26.72 −$1.03 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.20 +1.82%
Open$27.26
Prev close$27.74
Day range$26.62 – $27.83
Volume2.13M
Market cap$4.65B
P/E (TTM)–
Dividend yield–

COGT Stock News

Headlines matching Cogent Biosciences or the COGT ticker, most recent first.

  • J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Announces Target Price $62Market news · 9 Sep 2026 · Direct mention
  • Wedbush Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55Market news · 17 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55Market news · 17 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55Market news · 16 Sep 2026 · Direct mention
  • Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $55 PositiveMarket news · 17 Aug 2026 · Direct mention
  • Guggenheim Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $52 PositiveMarket news · 12 Aug 2026 · Direct mention
  • Needham Maintains Cogent Biosciences(COGT.US) With Hold RatingMarket news · 11 Aug 2026 · Direct mention
  • Stifel Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45Market news · 15 Jun 2026 · Direct mention
  • UBS Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $60Market news · 1 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)TipRanks · 1 Jun 2026 · Direct mention
  • J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy RatingMarket news · 1 Jun 2026 · Direct mention
  • Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52Market news · 7 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cogent Biosciences(COGT.US), With a Forecast Between $45 to $55Market news · 6 May 2026 · Direct mention
  • Guggenheim Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45Market news · 2 Apr 2026 · Direct mention
  • H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52Market news · 2 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on COGT.

Sign in to join the discussion.

Scroll to Top